Deficiency of Toll-like receptors 2, 3 or 4 extends life expectancy in Huntington's disease mice

Kathleen Griffioen, Mark P. Mattson, Eitan Okun

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Abstract

Huntington's disease (HD), an autosomal dominant neurodegenerative disorder characterized by progressive striatal and cortical atrophy, has been strongly linked with neuroinflammation. Toll-like receptors, a family of innate immune receptors, are a major pathway for neuroinflammation with pleiotropic effects on neuronal plasticity and neurodevelopment. We assessed whether deficiency for TLRs 2, 3 or 4 affects life expectancy in the N171-82Q mouse model of HD. Our data indicate that homozygous TLRs 2 and 3 as well as heterozygous TLR4 deficiency significantly extends the life expectancy of HD mice. Our data suggest that multiple TLR pathways may be involved in the neuroinflammatory and degenerative processes during HD.

Original languageEnglish
Article numbere00508
JournalHeliyon
Volume4
Issue number1
DOIs
StatePublished - Jan 2018

Bibliographical note

Publisher Copyright:
© 2018 The Authors

Funding

This work was supported by the Intramural Research Program of the National Institute on Aging , and the Paul Feder Laboratory for Research on Neurodegenerative Disorders .

FundersFunder number
National Institute on Aging

    Keywords

    • Neurology
    • Neuroscience

    Fingerprint

    Dive into the research topics of 'Deficiency of Toll-like receptors 2, 3 or 4 extends life expectancy in Huntington's disease mice'. Together they form a unique fingerprint.

    Cite this